# EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

> **NCT06375967** · NA · SUSPENDED · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 128 (estimated)

## Conditions studied

- Malignant Biliary Obstruction
- Biliary Tract Neoplasms
- Pancreatic Cancer Non-resectable

## Interventions

- **PROCEDURE:** Endoscopic biliary drainage
- **DEVICE:** Lumen-apposing metal stent (LAMS) and double-pigtail plastic stent (DPPS)
- **DEVICE:** Lumen-apposing metal stent (LAMS) and double-pigtail plastic stent (DPPS)

## Key facts

- **NCT ID:** NCT06375967
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-10-18
- **Primary completion:** 2026-10
- **Final completion:** 2027-10
- **Target enrollment:** 128 (ESTIMATED)
- **Why stopped:** Class I Recall (Feb 2026): Boston Scientific issued a global recall for specific lots of AXIOS 6x8mm and 8x8mm due to reports of deployment and expansion failure during the procedure.
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375967, "EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06375967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*